VTRS - Viatris Inc logo

VTRS

Viatris Inc

Viatris Inc. develops, manufactures, and distributes prescription brand drugs, generics, complex generics, and biosimilars across therapeutic areas, serving patients through retail pharmacies, wholesalers, institutions, and direct providers globally.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 30 years ago โ†’$3,131today

Score Overview

1 Year
Score
Net Growth88.32%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth3.06%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth67.64%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-17.61%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score
Net Growth38.69%
Net Trend33%
Net Income Consistency
Rev Growth23.37%
Rev Trend33%
Revenue Consistency

See the full market ranking โ†’

Viatris Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 11.94B to $ 14.29B and net income went from -$ 669M to -$ 3.51B. Revenue increased in 1 of those 5 years; net income in 2.

Viatris Inc currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 16.10โ€”
1 Year2025-08-12
$ 9.7465.36%
5 Years2021-08-12
$ 12.1132.91%
10 Years2016-08-12
$ 38.99-58.71%
20 Years2006-08-11
$ 15.831.68%
30 Years1996-08-12
$ 5.14213.12%
All Time2020-11-16
$ 12.7626.17%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 14.73B-$ 410M$ 886M
2025$ 14.29B-$ 3.51B$ 1.45B
2024$ 14.73B-$ 634M$ 1.08B
2023$ 15.42B$ 54M$ 1.18B
2022$ 16.26B$ 2.07B$ 1.47B
2021$ 17.88B-$ 1.26B$ 935M
IPO2020$ 11.94B-$ 669M$ 1.04B

Explore beyond VTRS

You're looking at Viatris Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies